Thrombolytic Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC
Conditions: CVA (Cerebrovascular Accident) Interventions: Drug: alteplase or tenecteplase Sponsors: Chinese University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; Queen Mary Hospital, Hong Kong; Princess Margaret Hospital, Canada; Tuen Mun Hospital; The Queen Elizabeth Hospital; United Christian Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials

Relation of Laboratory Indices to Left Ventricular Thrombus Formation in Patients With Acute Anterior ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention or Thrombolytic Therapy
Conditions: Left Ventricular Thrombus Interventions: Other: Primary percutaneous coronary intervention or thrombolytic therapy Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials

Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China
Conditions: Ischemic Stroke Interventions: Drug: Tenecteplase; Drug: Alteplase Sponsors: Huashan Hospital; Keshiketeng Banner Traditional Chinese Medicine Mongolian Medicine Hospitalorem Ipsum; Nanshi Hospital of Nanyang; The First Affiliated Hospital of Ningbo University; Jilin Liuhe Hospital; Shenyang Fifth People ' s hospital; Shanghai East Hospita; Shanghai 10th People ' s Hospital; Shanghai Fifth People ' s Hospital; Shanghai Pudong Gongli hospital; Shanghai Neuromedical Center; Shanghai Fourth People ' s Hospital; Shanghai Pudong People ' s Hospital; Shanghai Putuo Liqun Hospital; Shenyang Fushun general hospital of ...
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials

Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial
DiscussionWhen dual thrombolytic therapy with a small bolus alteplase and m-proUK shows the anticipated effect on the outcome, this will lead to a 13% absolute reduction in the occurrence of ICH in patients with ischemic stroke.Trial registrationNL7409 (November 26, 2018)/NCT04256473 (February 5, 2020) (Source: Trials)
Source: Trials - August 9, 2022 Category: Research Source Type: clinical trials

Predictive Study of Serum Endocan for Hemorrhagic Transformation After Thrombolytic Therapy in Acute Ischemic Stroke
Condition: Acute Ischemic Stroke Intervention: Diagnostic Test: enzyme-linked immunosorbent assay(ELISA) Sponsor: Xijing Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2022 Category: Research Source Type: clinical trials

Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke
Condition: The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase Intervention: Drug: Revelisa Sponsor: Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2020 Category: Research Source Type: clinical trials